AwardsFeatured Awards 40 Under 40: Andrew Stergachis, University of Washington Puget Sound Business Journal | April 25, 2023 Genome mapping made Andrew Stergachis feel "like a kid in a candy store, being able…sciencecityApril 25, 2023 Read More
Local News Early Research May Show New Way to Block Dengue and Zika Virus Fred Hutch | April 25, 2023 Researchers at Seattle’s Fred Hutchinson Cancer Center have discovered a potent antibody that appears to…sciencecityApril 25, 2023 Read More
AwardsFeatured Awards Rachel Lex Receives ACS Fellowship to Uncover Regional Factors Driving Tumor Development Fred Hutch | April 24, 2023 We have mutated cells throughout our bodies. But whether one of those mutated cells grows…sciencecityApril 24, 2023 Read More
Local News How This Ukrainian-Born CEO Created a Biotech Startup ‘Where Curious Scientists Thrive’ GeekWire | April 24, 2023 Ivan Liachko didn’t plan on becoming a founder. But when the berry company called, the Ukrainian-born…sciencecityApril 24, 2023 Read More
Local News Icosavax Initiates Phase 1/2 Trial of COVID-19 VLP Vaccine Candidate Icosavax | June 9, 2021 Icosavax, Inc. today announced the first subjects have been dosed with IVX-411, a virus-like particle…kchenJune 9, 2021 Read More
Local News Prostate Cancer Researcher Dr. Janet Stanford Retires after Three Decades Fred Hutch | June 4, 2021 After more than 30 years at Fred Hutchinson Cancer Research Center, primarily studying prostate cancer…kchenJune 4, 2021 Read More
Local News BBI Faculty Conversations: Dr. Sarah Leary Brotman Baty Institute (BBI) | June 3, 2021 Today’s installment is with BBI member Dr. Sarah Leary. Dr. Leary is an attending physician…kchenJune 3, 2021 Read More
Local News Nanoparticle Flu Shot Blocks Seasonal and Pandemic Strains Institute for Protein Design | June 3, 2021 IPD researchers together with collaborators at the National Institutes of Health have developed experimental flu…kchenJune 3, 2021 Read More
Publications of the Week A First-in-Human, Open-Label Phase 1b and a Randomised, Double-Blind Phase 2a Clinical Trial in Recent-Onset Type 1 Diabetes with AG019 As Monotherapy and in Combination with Teplizumab Mathieu, C., et al. | December 13, 2023 We hypothesised that islet beta cell antigen presentation in the gut along with a tolerising…karnottDecember 13, 2023 Read More
Local News ‘1 in 1,000:’ Dr. Sean Gibbons Named Highly Cited Researcher for 2023 Institute for Systems Biology | December 12, 2023 ISB Associate Professor Dr. Sean Gibbons was named a Highly Cited Researcher for 2023. This…karnottDecember 12, 2023 Read More
Local News BBI’s Long-Read Sequencing Symposium Called ‘Inspirational’ Brotman Baty Institute | December 11, 2023 Dr. Danny Miller, the scientific advisor to BBI’s Long Read Sequencing Symposium on November 15,…karnottDecember 11, 2023 Read More